[1] |
GUI Jinmin, XUE Rui, LI Na, LIU Qinglin, ZHAO Donghong.
Individualized Management of Blood Pressure and Liquid Control for Moyamoya Patients with Hyperperfusion Syndrome after Extracranial-Intracranial Bypass
[J]. Chinese Journal of Stroke, 2022, 17(12): 1350-1354.
|
[2] |
LI Rujuan, YANG Chuan, MA Xiaohui, HOU Huanfeng, FU Huijie, MA Xiaodan, FANG Juntao, JIN Jinling, YANG Jinbo.
Digital Subtraction Angiography Evaluation of Collateral Compensation in Asymptomatic Middle Cerebral Artery Occlusion
[J]. Chinese Journal of Stroke, 2022, 17(12): 1355-1359.
|
[3] |
LIU Yajie, LI Yudi, LI Kaifeng, CHEN Zhefeng, LING Li.
Mechanism of Buyanghuanwu Decoction in Treatment of Cerebral Infarction Mice Based on High-Throughput
RNA Sequencing Technology
[J]. Chinese Journal of Stroke, 2022, 17(11): 1238-1246.
|
[4] |
HAN Guangsong, NI Jun.
Advances in Clinical Classification of Moyamoya Disease
[J]. Chinese Journal of Stroke, 2022, 17(10): 1120-1126.
|
[5] |
FU Heguan, SHEN Xuxuan, XU Jiali, ZHANG Houdi, LI Bin, ZOU Zhengxing, FENG Jie, DUAN Lian, HAN Cong.
The Types and Risk Factors of Stroke in Young Patients with Moyamoya Disease
[J]. Chinese Journal of Stroke, 2022, 17(09): 937-943.
|
[6] |
HE Junfang, LIU Xinping, LYU Xuehai, WAGN Bin.
The Protective Effect of Adiponectin on Rats with Cerebral Ischemia-reperfusion through PI3K/PKB Signaling Pathway
[J]. Chinese Journal of Stroke, 2022, 17(08): 857-862.
|
[7] |
KANG Shuai, HAN Heze, LU Junlin, CHEN Xiaolin, CHEN Yu, YE Xun, WANG Rong, ZHAO Yuanli.
Incidence and Risk Factors of Non-infective Fever after Cerebral Revascularization in Moyamoya Disease
[J]. Chinese Journal of Stroke, 2022, 17(07): 742-747.
|
[8] |
BAO Xiangyang, DUAN Lian.
Cultivation and Teaching Experience of Postgraduates in Moyamoya Disease
[J]. Chinese Journal of Stroke, 2022, 17(04): 426-428.
|
[9] |
ZHANG Xin-Miao, WANG Chun-Juan, YANG Xin, GU Hong-Qiu, JIANG Ying-Yu, WANG Yi-Long, ZHAO Xing-Quan, LI Zi-Xiao, WANG Yong-Jun.
Safety of Intravenous Thrombolysis in Acute Ischemic Stroke Patients with Antithrombotic Therapy before Stroke Onset
[J]. Chinese Journal of Stroke, 2021, 16(11): 1110-1114.
|
[10] |
LU Qing-Li, WANG Jing, LIU Zhong-Zhong, LIU Pei, LIU Yan, CHANG Qiao-Qiao, LIN Xue-Mei, SHI Ya-Ling, WANG Fang, WU Song-Di.
Clinical Characteristics and 1-Year Prognosis of First-ever Cerebral Infarction Patients with Atrial Fibrillation in Xi'an
[J]. Chinese Journal of Stroke, 2021, 16(11): 1131-1136.
|
[11] |
ZHAO Dong-Hong, ZHANG Dong, XUE Rui, YUAN Qiao-Ling.
Application of Personalized Cognitive Function Nursing and Training in Adult Patients with Moyamoya Diseaseafter Surgical Revascularization
[J]. Chinese Journal of Stroke, 2021, 16(11): 1144-1149.
|
[12] |
ZHANG Xue-Lei, MIAO Zhong-Rong, LIU Wei.
Efficacy and Safety of Endovascular Therapy for Acute Ischemic Stroke Patients with Large Infarct Core
[J]. Chinese Journal of Stroke, 2021, 16(09): 901-908.
|
[13] |
LIN Lin, LIU Dun, MENG Qing-Wei, LI Shuang, WANG Tao.
Application of Clinical Decision Support System in Antithrombotic Therapy for Cerebral Infarction Patients with Atrial Fibrillation#br#
[J]. Chinese Journal of Stroke, 2021, 16(09): 975-978.
|
[14] |
LU Qing-Li, LIU Zhong-Zhong, LIU Pei, CHANG Qiao-Qiao, LIU Yan, WANG Jing, LIN Xue-Mei, WANG Fang, SHI Ya-Ling, WU Song-Di.
Clinical Characteristics and 1-Year Prognosis of Patients with Acute Recurrent Cerebral Infarction in Xi’an
[J]. Chinese Journal of Stroke, 2021, 16(08): 787-792.
|
[15] |
HOU Rui-Hua, LYU Mai-Kou, WEN Hui-Jun.
Correlation between D-dimer to Fibrinogen Ratio and Carotid Plaque in Young Patients with Acute Cerebral Infarction
[J]. Chinese Journal of Stroke, 2021, 16(08): 805-809.
|